The promise of gene editing to upend how we treat heart disease and transform pharma

Advertisement
The promise of gene editing to upend how we treat heart disease and transform pharma
Scientists in Beam Therapeutics' laboratory in Cambridge, Massachusetts Beam

Hello,

Advertisement

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...


Investors are betting billions that cutting-edge cures can upend how we treat heart disease and transform pharma

Take a look>>


Advertisement

The US is helping millions of people get faster internet, and it could shape the next phase of telehealth

Get the full story>>


The promise of gene editing to upend how we treat heart disease and transform pharma
A woman receives the COVID-19 vaccine in Wales, UK. Matthew Horwood/Getty

You will know, or possibly be, someone who gets COVID-19 after a vaccine

Here's what to expect>>


More stories we're reading:


- Lydia

{{}}